U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794502) titled 'Butterfly Pea Flower (Clitoria Ternatea) for Adjuvant TB Treatment' on Jan. 20.
Brief Summary: The goal of this clinical trial is to learn if butterfly pea flowers (Clitoria ternatea) decocta extract works to treat as adjuvant therapy for tuberculosis in adults. It will also learn about the safety of butterfly pea flowers decocta extract.
The main questions it aims to answer are:
* Does butterfly pea flower extract as an adjunct TB drug therapy drug affect the profiles of interferon gamma and interleukin-10 of people with tuberculosis?
* Does butterfly pea flower extract as an adjunct TB drug therapy drug affect the hematology pr...